Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
4.110
+1.050 (34.31%)
At close: Oct 16, 2026, 4:00 PM EDT
4.220
+0.110 (2.68%)
Pre-market: Oct 19, 2026, 7:45 AM EDT

Cytosorbents Revenue

Cytosorbents had revenue of $9.63M in the quarter ending June 30, 2026, with 0.17% growth. This brings the company's revenue in the last twelve months to $37.22M, up 3.07% year-over-year. In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.12% growth. That makes Cytosorbents the 29,973rd largest company in the world by revenue and 3,978th in the United States.

Revenue (ttm)
$37.22M
Revenue Growth
+3.07%
P/S Ratio
0.35
Revenue / Employee
$288,496
Employees
129
Market Cap
12.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202537.06M1.47M4.12%
Dec 31, 202435.60M4.51M14.51%
Dec 31, 202331.08M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 201924.95M2.45M10.87%
Dec 31, 201822.50M7.35M48.53%
Dec 31, 201715.15M5.62M59.02%
Dec 31, 20169.53M4.74M98.84%
Dec 31, 20154.79M668.79K16.22%
Dec 31, 20144.12M1.70M70.18%
Dec 31, 20132.42M1.08M80.40%
Dec 31, 20121.34M1.31M3,622.31%
Dec 31, 201136.08K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Accuray401.95M
IRIDEX51.57M
Lifeward21.82M
Pulsenmore14.13M
NeuroOne Medical Technologies12.47M
InspireMD10.84M
Biomerica4.34M
Sintx Technologies1.33M
Revenue Rankings